Radiation necrosis is a rare but disabling complication of radiation therapy to the brain and currently there is no cure. The trial is the first in the world to intra-arterially administer Avastin, a cancer drug, directly to the affected part of the brain for treatment of radiation necrosis.
The University of Kentucky Center on Drug and Alcohol Research led a multi-site clinical drug trial that rendered positive results regarding the potential of a new injectable therapy for opioid use disorders.
CLIK is an intensive training program that enhances the capacity of leaders and communities to reduce health disparities, leverage funding and use data to improve services and programs.
A new study by University of Kentucky Markey Cancer Center researchers shows that chloroquine – a drug currently used to treat malaria – may be useful in treating patients with metastatic cancers.